← Leaderboards
Alberto Mendoza
Socios En Salud Sucursal Peru
$265,356
Attributed
$265,356
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $134.3K · FY2024–25$200K$150K$100K$50K$0
'24
'25
Funding mix
By agency
NIH$265,356 · 1
By mechanism
R01$265,356 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Adult”
- Jennifer Lee O'Brien · University Of South Florida$15,110,862
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- Daofeng Li · Salk Institute For Biological Studies$9,887,266
- Gregory Sorenson · University Of Maryland Baltimore County$9,161,697
- April Carson · University Of Mississippi Med Ctr$9,022,104
- Christine W Hockett · Avera Mckennan$8,908,366
Research focus
AdultAftercareAlternative TreatmentAdverse EventBloodCause Of DeathCenters For Disease Control And Prevention (U.S.)Clinically SignificantClinical ResearchBactericideCohortCollaborationsCommunicable DiseasesCountryCovid-19DangerousnessDesignDosageDoseDrug KineticsDrug Resistance In TuberculosisClinical RiskEarly TreatmentEffectiveness
Grant awards (2)
Treatment of isoniazid-resistant tuberculosis: closing evidence gaps on safety, effectiveness, and pharmacokinetics of the standard regimen$131,016
R01 · FY2025 · AI · contact PI
Treatment of isoniazid-resistant tuberculosis: closing evidence gaps on safety, effectiveness, and pharmacokinetics of the standard regimen$134,340
R01 · FY2024 · AI · contact PI